CG Oncology News

CG Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)

Oct 22 18:11 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Roche Corleen M.

Oct 8 09:31 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kuan Arthur

Oct 7 17:24 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director POST LEONARD E

Oct 7 17:21 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director Graf Susan E

Oct 7 17:13 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director Liu Brian Guan-Chyun

Oct 7 17:13 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director Tong Victor Edward Jr

Oct 7 17:12 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kasturi Vijay

Oct 7 17:11 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director Song Hong Fang

Oct 7 17:09 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Bellete Ambaw

Oct 7 17:04 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director Mulay James

Oct 7 17:04 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Patterson Joshua F.

Oct 7 17:03 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director Song Hong Fang

Aug 30 19:23 ET

CG Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-SONG, Hong Fang(8.3%),Healthcare Seed Limited(7.4%), etc.

Jul 22 16:37 ET

CG Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Patterson Joshua F.

May 16 19:02 ET

CG Oncology | 3: Initial statement of beneficial ownership of securities-Officer Patterson Joshua F.

May 16 17:14 ET

CG Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Xiangmin Cui(8.2%),Decheng Capital Global Life Sciences Fund IV, L.P.(7.4%), etc.

Apr 9 19:16 ET

CG Oncology | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Decheng Capital Global Life Sciences Fund IV, L.P.

Apr 9 19:11 ET

CG Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kissei Pharmaceutical Co., Ltd.(5.3%)

Mar 14 19:30 ET

CG Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP I, LLC(5.4%),TCG Crossover Fund I, L.P.(5.4%), etc.

Feb 9 16:39 ET